CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
Clinical trial NCT02697136 · TERMINATED
Trial details
- NCT number
- NCT02697136
- Sponsor
- Cerenis Therapeutics, SA
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.